Stay updated on Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial

Sign up to get notified when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page. This reflects a new page version being published.
    Difference
    0.0%
    Check dated 2026-03-21T09:14:13.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Added related topics: Multiple myeloma and MedlinePlus Genetics to the page. This provides contextual information about the disease and access to genetics resources for readers.
    Difference
    0.1%
    Check dated 2026-03-13T22:29:04.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-06T18:22:39.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Related topics links for Multiple Myeloma and MedlinePlus Genetics were removed from the page.
    Difference
    0.1%
    Check dated 2026-02-27T19:09:19.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The DREAMM-3 study locations were updated to add and remove sites, with the page now indicating 102 locations (including Omaha, NE and Shibuya-Ku, Tokyo) and a revision to version 3.4.2.
    Difference
    2%
    Check dated 2026-02-13T13:41:22.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.0 to v3.4.1 is displayed. This appears to be a non-substantive UI/version update and does not modify study content or parameters.
    Difference
    0.0%
    Check dated 2026-02-05T23:48:43.000Z thumbnail image

Stay in the know with updates to Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.